-
LRRC8A–Caveolin-1 Signaling in PDAC Growth
2026-08-24
The reference study identifies a cholesterol-dependent LRRC8A–Caveolin-1 axis that links cell-volume regulation to KRAS/EGFR signaling, ribosome biogenesis, and biosynthetic growth in pancreatic ductal adenocarcinoma. Its integrated genetic, pharmacological, organoid, xenograft, and proteomic experiments position membrane organization as a mechanistic determinant of tumor-cell expansion and a potential vulnerability.
-
AZD1390 and G4 Stress in ATM Research
2026-08-24
Explore how AZD1390, a selective ATM kinase inhibitor, can separate DNA damage signaling from G-quadruplex replication stress. This article translates REV1–DHX36 findings into a rigorous assay framework for radiosensitization and cancer research.
-
CD36 Lipid Signaling Drives Immune Escape in AML
2026-08-23
A 2024 Cell Reports Medicine study identifies a non-canonical CD36 lipid-sensing program that enables AML cells to suppress T-cell activity and resist decitabine. The work connects OxLDL and palmitate uptake to TLR4-LYN-MYD88-NF-κB signaling and shows that statin-mediated lipid restriction can improve decitabine responses in preclinical models.
-
Phenytoin for Dynamic Myelin Damage Assays
2026-08-22
Phenytoin can help dissect how sodium-channel-dependent excitability influences early myelin damage. This assay-focused guide translates longitudinal myelin imaging findings into practical electrophysiology, dosing, timing, and interpretation decisions.
-
IWP-L6: A Functional Wnt Signaling Research Map
2026-08-22
IWP-L6 is a sub-nanomolar Porcupine inhibitor for dissecting Wnt signaling modulation across developmental and metabolic assays. This guide connects upstream Porcn enzyme inhibition with assay timing, branching morphogenesis, regeneration, and Wnt-driven osteoblast metabolism.
-
Sex Differences in Angiotensin II Hypertension
2026-08-21
Xue, Pamidimukkala, and Hay showed that chronic angiotensin II produces a substantially larger hypertensive response in conscious male mice than in female mice, with gonadectomy shifting the response in both sexes. Telemetry, baroreflex testing, and ganglionic blockade linked this sex difference to hormone-dependent cardiovascular regulation and a greater sympathetic contribution in males.
-
Adiponectin, TLR4, and Cognitive Deficits After Splenectomy
2026-08-20
This reference study uses an aged-rat splenectomy model to connect adiponectin treatment with reduced neuroinflammation, oxidative stress, and postoperative cognitive impairment. Pharmacological comparison with TAK-242 and LPS supports a mechanistic role for the TLR4/MyD88/NF-κB axis, while also highlighting important limits for translating pretreatment findings to clinical perioperative neurocognitive disorder.
-
In Situ CAR Macrophage Programming for Peritoneal Tumors
2026-08-20
Gu et al. develop a macrophage-targeted mRNA lipid nanoparticle platform for programming CAR macrophages directly in the peritoneal cavity and use it to compare 36 CAR designs. The CD3ζ–TLR4 intracellular-domain configuration promoted inflammatory macrophage activity, remodeled the tumor microenvironment, increased TCF1+PD-1+ progenitor-exhausted CD8+ T cells, and enhanced responses to PD-1/PD-L1 blockade.
-
Rhodamine 123 Transport Assay Workflows
2026-08-19
Build sensitive, low-disruption workflows for real-time P-glycoprotein activity, uptake kinetics, and membrane transport process analysis. This guide also shows how to use Rhodamine 123 alongside ABCG2-focused chemosensitization studies without confusing transporter-specific readouts.
-
VX-745 Workflow for p38α MAPK Research
2026-08-19
VX-745 provides a practical way to connect p38α MAPK inhibition with cytokine secretion, cell survival, and disease-model endpoints. This workflow emphasizes formulation control, time-resolved signaling assays, and orthogonal validation for inflammation, aging, and multiple myeloma research.
-
Berberine, Tuft Cells, and Estrogen-Deficiency Bone Loss
2026-08-18
A 2026 Phytomedicine study identifies an intestine-to-bone mechanism in which berberine increases microbial butyrate, activates GPR41, and expands intestinal tuft cells. In ovariectomized models, this pathway restored gut barrier function and improved the Th17/Treg imbalance associated with estrogen deficiency, providing a mechanistic framework for postmenopausal osteoporosis research.
-
RITA (NSC 652287): p53 Research Profile
2026-08-18
RITA (NSC 652287) is a small-molecule inhibitor of the MDM2-p53 interaction with reported activity in renal carcinoma and other tumor models. Its cross-linking activity and strong xenograft responses require orthogonal viability and cell-death assays rather than reliance on a single growth endpoint.
-
Cy5-UTP for RNA Probe Synthesis and FISH
2026-08-17
Cy5-UTP enables direct fluorescent RNA probe synthesis by T7 RNA polymerase, supporting FISH, dual-color expression arrays, and live-cell RNA trafficking assays. This practical guide connects labeling chemistry with the ANXA7–TIA1 axonal transport findings and shows how to optimize signal without compromising RNA behavior.
-
NSC 87877: A Practical Shp2 Inhibitor Guide
2026-08-17
NSC 87877 is a potent Shp2 inhibitor for dissecting phosphatase-dependent signaling in microglia, cancer models, and inflammatory pain research. This guide translates the SHP2/NLRP3 findings from a focused-ultrasound stroke study into practical assay designs, formulation choices, and troubleshooting workflows.
-
CAPE and NF-κB in Translational Research
2026-08-16
Caffeic Acid Phenethyl Ester (CAPE) is more than a catalog NF-κB inhibitor: it can serve as a mechanistic perturbation tool for connecting inflammatory signaling with angiogenesis, tumor invasion, and Fyn–Stat3 biology in neurodegeneration models.